Sanofi's BTK inhibitor Wayrilz has become the first drug in the class to be approved by the FDA for immune thrombocytopenia (ITP), a rare autoimmune blood disorder. Wayrilz (rilzabrutinib) has been ...
Shares in Sanofi were sliding today after a double dose of bad news for its oral BTK inhibitor tolebrutinib, in development as a therapy for multiple sclerosis (MS). Along with what looks set to be ...
Generated by create next app'My Father BTK' - a 2-Hour 20/20 Documentary Event Special - Tonight at 9/8c on ABC The notorious serial killer that terrified and shocked the nation - BTK. Now, his ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback